Intervention to Support Partners and Informal Caregivers of Frail RA-patients

by palligoelme@gmail.com | Mar 4, 2026 | Clinical Trials

​ Conditions: Rheumatic Arthritis Interventions: Behavioral: Caregiver support Sponsors: Glostrup University Hospital, Copenhagen Not yet recruiting Conditions: Rheumatic Arthritis Interventions: Behavioral: Caregiver support Sponsors: Glostrup University Hospital,...

Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies

by palligoelme@gmail.com | Mar 4, 2026 | Clinical Trials

​ Conditions: Cervical Cancer; Radiation Therapy Complication; Pelvic Floor Disorders Interventions: Procedure: Pelvic floor physical therapy Sponsors: University of Cincinnati Not yet recruiting Conditions: Cervical Cancer; Radiation Therapy Complication; Pelvic...

SII Levels Following PENG Block in Hip Arthroplasty

by palligoelme@gmail.com | Mar 4, 2026 | Clinical Trials

​ Conditions: Hip Osteoarthritis Interventions: Drug: sodium Chloride; Drug: Ropivacaine 0.2% Injectable Solution Sponsors: Poznan University of Medical Sciences Not yet recruiting Conditions: Hip Osteoarthritis Interventions: Drug: sodium Chloride; Drug: Ropivacaine...

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

by palligoelme@gmail.com | Mar 3, 2026 | Clinical Trials

​ Conditions: Resectable Hepatocellular Carcinoma Interventions: Drug: ateganosine; Drug: Cadonilimab Sponsors: University of Texas Southwestern Medical Center; Maia Biotechnology; National Cancer Institute (NCI) Not yet recruiting Conditions: Resectable...

A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma

by palligoelme@gmail.com | Mar 3, 2026 | Clinical Trials

​ Conditions: Advanced Esophageal Squamous Cell Carcinoma Interventions: Drug: anlotinib combined with benmelstobart; Drug: Toripalimab Combined with Chemotherapy Sponsors: The First Affiliated Hospital of Zhengzhou University Not yet recruiting Conditions: Advanced...